Sign Up to like & get recommendations! 2
Published in 2021 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2021.1910
Abstract: This randomized clinical trial evaluates the effect of postoperative radiotherapy on survival and safety in patients with pIIIA-N2 non–small cell lung cancer after complete resection and adjuvant chemotherapy. read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2022.4442
Abstract: This Viewpoint discusses 2 recent randomized clinical trials evaluating the role of mediastinal postoperative radiotherapy in patients with non–small cell lung cancer. read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25308
Abstract: To investigate the role of postoperative radiotherapy (PORT) in IIIA‐N2 non–small cell lung cancer (NSCLC) patients and subgroups which derived benefit from PORT. read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Clinical and Translational Oncology"
DOI: 10.1007/s12094-020-02474-9
Abstract: To investigate the magnetic resonance imaging (MRI) images of brain glioma before postoperative radiotherapy, and to provide reference for the delineation of postoperative radiotherapy target area. Retrospective analysis was performed on 106 cases of brain… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "International journal of oral and maxillofacial surgery"
DOI: 10.1016/j.ijom.2020.06.006
Abstract: The effectiveness of postoperative radiotherapy (PORT) in improving outcomes remains debatable for oral squamous cell carcinoma (OSCC) patients with pathological intermediate-risk factors (IRFs) after surgery. A retrospective analysis was conducted on 432 intermediate-risk OSCC patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Surgery"
DOI: 10.1016/j.surg.2021.01.034
Abstract: BACKGROUND This study aimed to investigate the survival benefit of postoperative radiotherapy in patients with resected human papilloma virus-positive oropharyngeal squamous cell carcinoma using data from the Surveillance, Epidemiology, and End Results database. METHODS A… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "World neurosurgery"
DOI: 10.1016/j.wneu.2022.03.053
Abstract: PURPOSE It remained controversial that whether patients with atypical meningiomas can benefit from postoperative radiotherapy (PORT) after gross total resection (GTR). This study aimed to explore the effectiveness of PORT on atypical meningioma patients after… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Scientific Reports"
DOI: 10.1038/s41598-018-30710-4
Abstract: This study aimed to quantitatively compare radiation dermatitis due to hypofractionated (Hypo) and conventionally fractionated (Conv) external-beam radiotherapy in patients who underwent postoperative radiotherapy after breast-conserving surgery. Skin color changes, in terms of L* (brightness,… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noaa222.780
Abstract: Abstract INTRODUCTION Postoperative radiotherapy is commonly given for WHO Grade 2–3 intracranial ependymoma. Clinicians generally aim to begin radiotherapy ≤5 weeks following surgery, but the optimal timing remains uncertain. METHODS The National Cancer Database was… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Medicine"
DOI: 10.1097/md.0000000000026000
Abstract: Abstract Background: This meta-analysis evaluates the difference of sparing organs at risk (OAR) in different position (Prone position and Supine position) with different breathing patterns (Free breathing, FB/Deep inspiration breath hold, DIBH) for breast cancer… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.13749
Abstract: The aim of this study was to evaluate the efficacy of postoperative radiotherapy (PORT) in stage pIIIA‐N2 non‐small cell lung cancer (NSCLC) patients with positive surgical margins. read more here.